This post was originally published on this site
Gritstone Oncology Inc (NASDAQ:GRTS) 39% HIGHER; as awarded a contract by the Biomedical Advanced Research and Development Authority (BARDA) to conduct a Phase 2b comparative study evaluating Gritstones self-amplifying mRNA (samRNA) vaccine candidate containing Spike plus other viral targets to protect against COVID-19. The agreement, which is valued at up to $433 million, was awarded as part of Project NextGen, an initiative by the U.S. Department of Health and Human Services (HHS) to advance a pipeline of new, innovative vaccines and therapeutics providing broader and more durable protection for COVID-19
Peloton (NASDAQ:PTON) 13% HIGHER; lululemon (NASDAQ:LULU) and Peloton announced a five-year strategic global partnership through which Peloton will become the exclusive digital fitness content provider for lululemon, and lululemon will become the primary athletic apparel partner to Peloton.
Opera Limited (NASDAQ:OPRA) 6% LOWER; announced that it has commenced an underwritten secondary public offering of 6,876,506 American Depositary Shares from a pre-IPO shareholder.
Worthington Industries (NYSE:WOR) 6% LOWER; reported Q1 EPS of $2.06, $0.02 better than the analyst estimate of $2.04. Revenue for the quarter came in at $1.2 billion versus the consensus estimate of $1.23B.
Micron Technology (NASDAQ:MU) 4% LOWER; reported Q4 EPS of ($1.07), $0.08 better than the analyst estimate of ($1.15). Revenue for the quarter came in at $4.01B versus the consensus estimate of $3.93B. Micron Technology sees Q1 2024 EPS of ($1.00)-($1.14), versus the consensus of ($0.90). Micron Technology sees Q1 2024 revenue of $4.2-4.6B, versus the consensus of $3.97B.
Jefferies Financial Group Inc (NYSE:JEF) 3% LOWER; reported Q3 EPS of $0.22, $0.10 worse than the analyst estimate of $0.32. Revenue for the quarter came in at $1.18B versus the consensus estimate of $1.24B.
Duckhorn Portfolio Inc (NYSE:NAPA) 2% LOWER; reported Q4 EPS of $0.15, $0.02 better than the analyst estimate of $0.13. Revenue for the quarter came in at $100.1M versus the consensus estimate of $99.86M. The Duckhorn Portfolio, Inc. sees FY2024 EPS of $0.67-$0.69. The Duckhorn Portfolio, Inc. sees FY2024 revenue of $420-430M.
